Limits of patient isolation measures to control extended-spectrum beta-lactamase-producing Enterobacteriaceae: model-based analysis of clinical data in a pediatric ward

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Domenech de Cellès, Matthieu ^a,b,c,f   Zahar, Jean Ralph ^d,e   Abadie, Véronique ^d,e   Guillemot, Didier ^a,b,f,g  

^a INSTITUT PASTEUR   (France)

^b INSERM   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f University Versailles Saint Quentin UVSQ   (France)

^g RAYMOND POINCARÉ HOSPITAL   (France)

Author keywords

Bacterial pathogens; ESBL E; Healthcare epidemiology; Mathematical modeling; Statistical inference

Indexed keywords

ANTIBIOTIC AGENT; EXTENDED SPECTRUM BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL METABOLISM; BACTERIAL TRANSMISSION; BACTERIUM CARRIER; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFICACY; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTION; ENZYME SYNTHESIS; HUMAN; INFECTION CONTROL; MATHEMATICAL MODEL; MEDICAL DECISION MAKING; NONHUMAN; OBSERVATIONAL STUDY; PATIENT CARE; PEDIATRIC WARD; PREDICTION; RETROSPECTIVE STUDY; STOCHASTIC MODEL;

ADOLESCENT; BETA-LACTAMASES; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; DISEASE TRANSMISSION, INFECTIOUS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; INFANT; MALE; MODELS, THEORETICAL; PATIENT ISOLATION; PEDIATRICS;

EID: 84876680867     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-187     Document Type: Article

References (41)

1. Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, Scheld M, Spellberg B, Bartlett J. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 2009, 48(1):1-12. 10.1086/595011, 19035777.
2. Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 2005, 18(4):657-686. 10.1128/CMR.18.4.657-686.2005, 1265908, 16223952.
3. Schwaber MJ, Carmeli Y. Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J Antimicrob Chemother 2007, 60(5):913-920. 10.1093/jac/dkm318, 17848376.
4. Friedmann R, Raveh D, Zartzer E, Rudensky B, Broide E, Attias D, Yinnon AM. Prospective evaluation of colonization with extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae among patients at hospital admission and of subsequent colonization with ESBL-producing Enterobacteriaceae among patients during hospitalization. Infect Control Hosp Epidemiol 2009, 30(6):534-542. 10.1086/597505, 19419270.
5. Kader AA, Kumar A, Kamath KA. Fecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in patients and asymptomatic healthy individuals. Infect Control Hosp Epidemiol 2007, 28(9):1114-1116. 10.1086/519865, 17932839.
6. Conly JM, McEwen S, Hutchinson J, Boyd N, Callery S, Bryce E. Canadian Committee on Antibiotic Resistance report. Can J Infect Dis Med Microbiol 2004, 15(5):257-260. 2094987, 18159502.
7. Kirkland KB. Taking off the gloves: toward a less dogmatic approach to the use of contact isolation. Clin Infect Dis 2009, 48(6):766-771. 10.1086/597090, 19196174.
8. Lowe C, Katz K, McGeer A, Muller MP. Disparity in infection control practices for multidrug-resistant Enterobacteriaceae. Am J Infect Control 2012, 40(9):836-839. 10.1016/j.ajic.2011.11.008, 22361360.
9. Macrae MB, Shannon KP, Rayner DM, Kaiser AM, Hoffman PN, French GL. A simultaneous outbreak on a neonatal unit of two strains of multiply antibiotic resistant Klebsiella pneumoniae controllable only by ward closure. J Hosp Infect 2001, 49(3):183-192. 10.1053/jhin.2001.1066, 11716635.
10. Paterson DL, Singh N, Rihs JD, Squier C, Rihs BL, Muder RR. Control of an outbreak of infection due to extended-spectrum beta-lactamase-producing Escherichia coli in a liver transplantation unit. Clin Infect Dis 2001, 33(1):126-128. 10.1086/320882, 11389506.
11. Shannon K, Fung K, Stapleton P, Anthony R, Power E, French G. A hospital outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae investigated by RAPD typing and analysis of the genetics and mechanisms of resistance. J Hosp Infect 1998, 39(4):291-300. 10.1016/S0195-6701(98)90294-8, 9749400.
12. Goddard S, Muller MP. The efficacy of infection control interventions in reducing the incidence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the nonoutbreak setting: a systematic review. Am J Infect Control 2011, 39(7):599-601. 10.1016/j.ajic.2010.09.018, 21621295.
13. Conterno LO, Shymanski J, Ramotar K, Toye B, Zvonar R, Roth V. Impact and cost of infection control measures to reduce nosocomial transmission of extended-spectrum beta-lactamase-producing organisms in a non-outbreak setting. J Hosp Infect 2007, 65(4):354-360. 10.1016/j.jhin.2006.12.014, 17289215.
14. Harris AD, McGregor JC, Furuno JP. What infection control interventions should be undertaken to control multidrug-resistant Gram-negative bacteria?. Clin Infect Dis 2006, 43(Suppl 2):S57-S61.
15. Stelfox HT, Bates DW, Redelmeier DA. Safety of patients isolated for infection control. JAMA 2003, 290(14):1899-1905. 10.1001/jama.290.14.1899, 14532319.
16. Gardam MA, Burrows LL, Kus JV, Brunton J, Low DE, Conly JM, Humar A. Is surveillance for multidrug-resistant enterobacteriaceae an effective infection control strategy in the absence of an outbreak?. J Infect Dis 2002, 186(12):1754-1760. 10.1086/345921, 12447761.
17. Forrester M, Pettitt AN. Use of stochastic epidemic modeling to quantify transmission rates of colonization with methicillin-resistant Staphylococcus aureus in an intensive care unit. Infect Control Hosp Epidemiol 2005, 26(7):598-606. 10.1086/502588, 16092739.
18. Kypraios T, O'Neill PD, Huang SS, Rifas-Shiman SL, Cooper BS. Assessing the role of undetected colonization and isolation precautions in reducing methicillin-resistant Staphylococcus aureus transmission in intensive care units. BMC Infect Dis 2010, 10:29. 10.1186/1471-2334-10-29, 2829569, 20158891.
19. Bonten MJ, Slaughter S, Ambergen AW, Hayden MK, van Voorhis J, Nathan C, Weinstein RA. The role of " colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch Intern Med 1998, 158(10):1127-1132. 10.1001/archinte.158.10.1127, 9605785.
20. Bootsma MC, Bonten MJ, Nijssen S, Fluit AC, Diekmann O. An algorithm to estimate the importance of bacterial acquisition routes in hospital settings. Am J Epidemiol 2007, 166(7):841-851. 10.1093/aje/kwm149, 17644823.
21. Pelupessy I, Bonten MJ, Diekmann O. How to assess the relative importance of different colonization routes of pathogens within hospital settings. Proc Natl Acad Sci USA 2002, 99(8):5601-5605. 10.1073/pnas.082412899, 122816, 11943870.
22. Zahar JR, Lanternier F, Mechai F, Filley F, Taieb F, Mainot EL, Descamps P, Corriol O, Ferroni A, Bille E. Duration of colonisation by Enterobacteriaceae producing extended-spectrum beta-lactamase and risk factors for persistent faecal carriage. J Hosp Infect 2010, 75(1):76-78. 10.1016/j.jhin.2009.11.010, 20227136.
23. Cooper BS, Stone SP, Kibbler CC, Cookson BD, Roberts JA, Medley GF, Duckworth GJ, Lai R, Ebrahim S. Systematic review of isolation policies in the hospital management of methicillin-resistant Staphylococcus aureus: a review of the literature with epidemiological and economic modelling. Health Technol Assess 2003, 7(39):1-194.
24. King AA, Ionides EL, Breto CM, Ellner S, Kendall B, Wearing H, Ferrari MJ, Lavine M, Reuman DC. pomp: statistical inference for partially observed Markov processes (R package). 2010, http://pomp.r-forge.r-project.org/.
25. R Development Core Team A Language and Environment for Statistical Computing 2012, Vienna, Austria: R Foundation for Statistical Computing, http://www.R-project.org/, R Development Core Team.
26. Gillespie DT. Exact stochastic simulation of coupled chemical-reactions. J Phys Chem 1977, 81(25):2340-2361.
27. Ionides EL, Breto C, King AA. Inference for nonlinear dynamical systems. Proc Natl Acad Sci USA 2006, 103(49):18438-18443. 10.1073/pnas.0603181103, 3020138, 17121996.
28. Raue A, Kreutz C, Maiwald T, Bachmann J, Schilling M, Klingmuller U, Timmer J. Structural and practical identifiability analysis of partially observed dynamical models by exploiting the profile likelihood. Bioinformatics 2009, 25(15):1923-1929. 10.1093/bioinformatics/btp358, 19505944.
29. Fankhauser C, Zingg W, Francois P, Dharan S, Schrenzel J, Pittet D, Harbarth S. Surveillance of extended-spectrum-beta-lactamase-producing Enterobacteriaceae in a Swiss tertiary care hospital. Swiss Med Wkly 2009, 139(51-52):747-751.
30. Harris AD, Kotetishvili M, Shurland S, Johnson JA, Morris JG, Nemoy LL, Johnson JK. How important is patient-to-patient transmission in extended-spectrum beta-lactamase Escherichia coli acquisition. Am J Infect Control 2007, 35(2):97-101. 10.1016/j.ajic.2006.09.011, 17327188.
31. Hilty M, Betsch BY, Bogli-Stuber K, Heiniger N, Stadler M, Kuffer M, Kronenberg A, Rohrer C, Aebi S, Endimiani A. Transmission dynamics of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the tertiary care hospital and the household setting. Clin Infect Dis 2012, 55(7):967-975. 10.1093/cid/cis581, 3436924, 22718774.
32. Donskey CJ. Antibiotic regimens and intestinal colonization with antibiotic-resistant Gram-negative bacilli. Clin Infect Dis 2006, 43(Suppl 2):S62-S69.
33. Ben-Ami R, Schwaber MJ, Navon-Venezia S, Schwartz D, Giladi M, Chmelnitsky I, Leavitt A, Carmeli Y. Influx of extended-spectrum beta-lactamase-producing Enterobacteriaceae into the hospital. Clin Infect Dis 2006, 42(7):925-934. 10.1086/500936, 16511754.
34. Thouverez M, Talon D, Bertrand X. Control of Enterobacteriaceae producing extended-spectrum beta-lactamase in intensive care units: rectal screening may not be needed in non-epidemic situations. Infect Control Hosp Epidemiol 2004, 25(10):838-841. 10.1086/502305, 15518025.
35. Kaier K, Mutters NT, Frank U. Bed occupancy rates and hospital-acquired infections-should beds be kept empty?. Clin Microbiol Infect 2012, 18(10):941-945. 10.1111/j.1469-0691.2012.03956.x, 22757765.
36. Temime L, Opatowski L, Pannet Y, Brun-Buisson C, Boëlle P-Y, Guillemot D. Peripatetic health-care workers as potential superspreaders. Proc Natl Acad Sci USA 2009, 106(43):18420-18425. 10.1073/pnas.0900974106, 2775324, 19841263.
37. Isella L, Romano M, Barrat A, Cattuto C, Colizza V, Van den Broeck W, Gesualdo F, Pandolfi E, Rava L, Rizzo C. Close encounters in a pediatric ward: measuring face-to-face proximity and mixing patterns with wearable sensors. PLoS One 2011, 6(2):e17144. 10.1371/journal.pone.0017144, 3046133, 21386902.
38. Ueno T, Masuda N. Controlling nosocomial infection based on structure of hospital social networks. J Theor Biol 2008, 254(3):655-666. 10.1016/j.jtbi.2008.07.001, 18647609.
39. Grundmann H, Hori S, Tanner G. Determining confidence intervals when measuring genetic diversity and the discriminatory abilities of typing methods for microorganisms. J Clin Microbiol 2001, 39(11):4190-4192. 10.1128/JCM.39.11.4190-4192.2001, 88515, 11682558.
40. McBryde ES, Pettitt AN, Cooper BS, McElwain DL. Characterizing an outbreak of vancomycin-resistant enterococci using hidden Markov models. J R Soc Interface 2007, 4(15):745-754. 10.1098/rsif.2007.0224, 2373397, 17360254.
41. Hollander R, Ebke M, Barck H, von Pritzbuer E. Asymptomatic carriage of Klebsiella pneumoniae producing extended-spectrum beta-lactamase by patients in a neurological early rehabilitation unit: management of an outbreak. J Hosp Infect 2001, 48(3):207-213. 10.1053/jhin.2001.0997, 11439008.